17β-hydroxysteroid dehydrogenase 3 deficiency in women

Journal of Clinical Endocrinology and Metabolism

Volumn 84, Issue 2, 1999, Pages 802-804

  Mendonca, Berenice B ^a   Arnhold, Ivo J P ^a   Bloise, Walter ^a   Andersson, Steffan ^b   Russell, David W ^c   Wilson, Jean D ^c  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TESTOSTERONE 17BETA DEHYDROGENASE; HYDROXYSTEROID DEHYDROGENASE; ISOENZYME;

ADULT; ARTICLE; CASE REPORT; CATALYSIS; ENZYME DEFICIENCY; FEMALE; GENE EXPRESSION REGULATION; GENE MUTATION; HOMOZYGOTE; HORMONE SYNTHESIS; HUMAN; MALE PSEUDOHERMAPHRODITISM; MISSENSE MUTATION; PEDIGREE; PRIORITY JOURNAL; SIBLING; FEMALE INFERTILITY; GENETICS; HETEROZYGOTE; MALE; MIDDLE AGED; MUTATION; PSEUDOHERMAPHRODITISM;

17-HYDROXYSTEROID DEHYDROGENASES; ADULT; FEMALE; HETEROZYGOTE; HOMOZYGOTE; HUMANS; INFERTILITY, FEMALE; ISOENZYMES; MALE; MIDDLE AGED; MUTATION; PEDIGREE; PSEUDOHERMAPHRODITISM;

EID: 0032588256     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.84.2.802     Document Type: Article

References (16)

1. 1. Andersson S, Russell DW, Wilson JD. 1996 17β-hydroxysteroid dehydrogenase deficiency. Trends Endocrinol Metab. 7:121-126.
2. 2. Saez JM, de Peretti E, Morera AM, David M, Bertrand J. 1971 Familial male pseudohermaphroditism with gynecomastia due to a testicular 17-ketoreductase deficiency. J Clin Endocrinol Metab. 32:604-610.
3. 3. Andersson S, Geissler WM, Wu L, et al. 1996 Molecular genetics and pathophysiology of 17β-hydroxysteroid dehydrogenase deficiency. J Clin Endocrinol Metab. 81:139-130-136.
4. 4. Moghrabi N, Hughes IA, Dunaif A, Andersson S. 1998 Deleterious missense mutations and silent polymorphism in the human 17β-hydroxysteroid dehydrogenase 3 gene (HSD17B3). J Clin Endocrinol Metab. 83:2855-2860, 1998.
5. 5. Rosler A, Silverstein S, Abeliovich D. 1996 A (R80Q) mutation in 17β-hydroxysteroid dehydrogenase type 3 gene among Arabs of Israel is associated with pseudohermaphroditism in males and normal asymptomatic females. J Clin Endocrinol Metab. 81:1827-1831.
6. 6. Geissler WM, Davis DL, Wu L, Bradshaw KD, Patel S, Mendonca BB, Elliston KO, Wilson JD, Russell DW, Andersson. 1994 Male pseudohermaphroditism caused by mutations of testicular 17-βhydroxysteroid dehydrogenase 3. Nature Genetics. 7:34-39.
7. 7. Arnhold IJP, Mendonca BB, Diaz JP, et al. 1988 Prepubertal male pseudohermaphroditism due to 17-ketoreductase deficiency: diagnostic value of a hCG test and lack of HLA association. J Endocrinol Invest. 11:319-322.
8. 8. Mendonca BB, Inacìo M, Costa EMF, Arnhold IJP, Sìlva, FAQ, Nicolau W, Bloise W, Russell DW, Wilson JD. 1996 Male pseudohermaphroditism due to steroid 5α-reductase deficiency. Medicine. 75:64-76.
9. 9. Thigpen AE, Davis Di, Milatovich A, et al. 1992 Molecular genetics of steroid 5α-reductase 2 deficiency. J Clin Invest. 90:799-809.
10. 10. Antonarakis SE, Kazazian HH, Tuddenham EGD. 1995 Molecular etiology of factor VIII deficiency in hemophilia A. Human Mutation. 5:1-22.
11. 11. Roberts RG, Gardner RJ, Bobrow M. 1994 Searching for the 1 in 2,400,000: a review of dystrophin gene point mutations. Human Mutation. 4:1-11.
12. 12. Eckstein B, Cohen S, Farkas S, Rosler A. 1989 The nature of the defect in familial male pseudohermaphroditism in Arabs of Gaza. J Clin Endocrinol Metab. 64:477-485.
13. 13. Zhang Y, Word RA, Fesmire S, Carr BR, Rainey WR. 1996 Human ovarian expression of 17β-hydroxysteroid dehydrogenase types 1, 2, and 3. J Clin Endocrinol Metab. 81:3594-3598.
14. 14. Mendonca BB, Russell AJ, Vasconcelos-Leite M, Arnhold IJ, Bloise W, Wajchenberg BL, Nicolau W, Sutcliffe RG, Wallace AM. 1994 Mutation in 3β-hydroxysteroid dehydrogenase type II associated with pseudohermaphroditism in males and premature pubarche or cryptic expression in females. J Mol Endocrinol. 12:119-122.
15. 15. Pang S, Softness B, Sweeny WJ, New MI. 1987 Hirsutism, polycystic ovarian disease, and 17-ketoreductase deficiency. N Engl J Med. 316:1295-1301.
16. 16. Zeitoun K, Ebaugh M, Carr BR, Bulun SE. 17β-HSD type 3 expression in a persistent ovarian tumor giving rise to recurrent gestational virilization. Abstracts, 80th Annual Meeting of The Endocrine Society, New Orleans, LA, June 24-27:1998, p 55.